Keith D. Eaton

A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer.

G. Giaccone, D. Dunlop, J. Nemunaitis, 2015, European journal of cancer.